Product NDC: | 66758-040 |
Proprietary Name: | Methotrexate Sodium |
Non Proprietary Name: | Methotrexate Sodium |
Active Ingredient(s): | 25 mg/mL & nbsp; Methotrexate Sodium |
Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66758-040 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090039 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090601 |
Package NDC: | 66758-040-08 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (66758-040-08) > 10 mL in 1 VIAL, SINGLE-DOSE (66758-040-07) |
NDC Code | 66758-040-08 |
Proprietary Name | Methotrexate Sodium |
Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (66758-040-08) > 10 mL in 1 VIAL, SINGLE-DOSE (66758-040-07) |
Product NDC | 66758-040 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methotrexate Sodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
Start Marketing Date | 20090601 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | METHOTREXATE SODIUM |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |